Matches in Wikidata for { <http://www.wikidata.org/entity/Q93024502> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q93024502 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q93024502 description "im August 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q93024502 description "scientific article published on 31 August 2019" @default.
- Q93024502 description "wetenschappelijk artikel" @default.
- Q93024502 description "наукова стаття, опублікована 31 серпня 2019" @default.
- Q93024502 name "Comparison of outcomes of continuation/discontinuation of 5-aminosalicylic acid after initiation of anti-tumor necrosis factor-alpha therapy in patients with inflammatory bowel disease" @default.
- Q93024502 name "Comparison of outcomes of continuation/discontinuation of 5-aminosalicylic acid after initiation of anti-tumor necrosis factor-alpha therapy in patients with inflammatory bowel disease" @default.
- Q93024502 type Item @default.
- Q93024502 label "Comparison of outcomes of continuation/discontinuation of 5-aminosalicylic acid after initiation of anti-tumor necrosis factor-alpha therapy in patients with inflammatory bowel disease" @default.
- Q93024502 label "Comparison of outcomes of continuation/discontinuation of 5-aminosalicylic acid after initiation of anti-tumor necrosis factor-alpha therapy in patients with inflammatory bowel disease" @default.
- Q93024502 prefLabel "Comparison of outcomes of continuation/discontinuation of 5-aminosalicylic acid after initiation of anti-tumor necrosis factor-alpha therapy in patients with inflammatory bowel disease" @default.
- Q93024502 prefLabel "Comparison of outcomes of continuation/discontinuation of 5-aminosalicylic acid after initiation of anti-tumor necrosis factor-alpha therapy in patients with inflammatory bowel disease" @default.
- Q93024502 P1433 Q93024502-D4430B96-033C-4AB5-B4A2-5EB60BFF4CF5 @default.
- Q93024502 P1476 Q93024502-32207382-3A31-47FA-864B-A035A22A2F8A @default.
- Q93024502 P2093 Q93024502-00C60DC8-9A67-4DD4-BD39-7A70C5A9BA7B @default.
- Q93024502 P2093 Q93024502-839C6D52-496D-45E2-BD07-0D59547F5E22 @default.
- Q93024502 P2093 Q93024502-D0C97DA6-16D3-4EC0-83A5-8AB3984E9537 @default.
- Q93024502 P2093 Q93024502-D9FCA3C8-A439-47A8-9CF0-3C763A7024CA @default.
- Q93024502 P2093 Q93024502-DCB7A482-54F8-42DC-AFA6-987E4DCF97C6 @default.
- Q93024502 P2093 Q93024502-DE735342-8E0E-4204-9BD6-3F56DCFB6968 @default.
- Q93024502 P304 Q93024502-7B1BD772-1A4E-40BD-AD77-AFFE933ECF69 @default.
- Q93024502 P31 Q93024502-B7557769-38E5-451C-AF57-4B9C25C1DE45 @default.
- Q93024502 P356 Q93024502-C680EB00-400E-4CBD-827B-8835718C0032 @default.
- Q93024502 P433 Q93024502-DA337BE6-909E-4687-A192-51D42865E263 @default.
- Q93024502 P478 Q93024502-CFCC8E5C-10E9-43C9-98F1-4D18B857232D @default.
- Q93024502 P50 Q93024502-868B9C6B-83F2-4292-A020-2AA3DC666ACE @default.
- Q93024502 P577 Q93024502-394C8ADF-C505-4B27-AE61-B4DE6FB335D6 @default.
- Q93024502 P698 Q93024502-DED99324-570F-4F3B-BCB4-D09ADC958100 @default.
- Q93024502 P921 Q93024502-D7B11B5B-EDA1-49B6-B451-7E116F99D0F9 @default.
- Q93024502 P356 S00384-019-03368-1 @default.
- Q93024502 P698 31471699 @default.
- Q93024502 P1433 Q15758189 @default.
- Q93024502 P1476 "Comparison of outcomes of continuation/discontinuation of 5-aminosalicylic acid after initiation of anti-tumor necrosis factor-alpha therapy in patients with inflammatory bowel disease" @default.
- Q93024502 P2093 "Dong Kyun Park" @default.
- Q93024502 P2093 "Jun-Won Chung" @default.
- Q93024502 P2093 "Kwang An Kwon" @default.
- Q93024502 P2093 "Kyoung Oh Kim" @default.
- Q93024502 P2093 "Tae Jun Kim" @default.
- Q93024502 P2093 "Yoon Jae Kim" @default.
- Q93024502 P304 "1713-1721" @default.
- Q93024502 P31 Q13442814 @default.
- Q93024502 P356 "10.1007/S00384-019-03368-1" @default.
- Q93024502 P433 "10" @default.
- Q93024502 P478 "34" @default.
- Q93024502 P50 Q90152057 @default.
- Q93024502 P577 "2019-08-31T00:00:00Z" @default.
- Q93024502 P698 "31471699" @default.
- Q93024502 P921 Q917447 @default.